Design and synthesis of statine-Containing BACE inhibitors-Reference-Cited by-同舟云学术

Design and synthesis of statine-Containing BACE inhibitors

Published:2003-12 Issue:24 Volume:13 Page:4335-4339
ISSN:0960-894X
Container-title:Bioorganic & Medicinal Chemistry Letters
language:en
Short-container-title:Bioorganic & Medicinal Chemistry Letters

Author:

Hu Jingdan,Cwi Cynthia L,Smiley David L,Timm David,Erickson Jon A,McGee James E,Yang Hsiu-Chiung,Mendel David,May Patrick C,Shapiro Mike,McCarthy James R

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference31 articles.

1. Inhibition of BACE, a Promising Approach to Alzheimers Disease Therapy

2. Aβ Modulation: The Next Generation of AD Therapeutics

3. Toward a Comprehensive Theory for Alzheimer's Disease. Hypothesis: Alzheimer's Disease Is Caused by the Cerebral Accumulation and Cytotoxicity of Amyloid β-Protein

4. In search of an enzyme: the β-secretase of Alzheimer's disease is an aspartic proteinase

5. Secretase Targets for Alzheimer's Disease: Identification and Therapeutic Potential

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Peptidomimetic Modulators of BACE1;Australian Journal of Chemistry;2020

2. Multidisciplinary approaches for targeting the secretase protein family as a therapeutic route for Alzheimer's disease;Medicinal Research Reviews;2019-01-09

3. Alzheimer's disease drug development based on Computer-Aided Drug Design;European Journal of Medicinal Chemistry;2016-10

4. Cognitive Enhancers (Nootropics). Part 2: Drugs Interacting with Enzymes. Update 2014;Journal of Alzheimer's Disease;2014-08-11

5. BACE1 (β-secretase) inhibitors for the treatment of Alzheimer's disease;Chem. Soc. Rev.;2014-04-02